FibroBiologics

March 02, 2026
Gene/Cell Therapy
Company Description: Based in Houston, FibroBiologics is a clinical-stage biotechnology company developing a pipeline of treatments and seeking potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. FibroBiologics holds 270+ US and internationally issued patents/patents pending across various clinical pathways, including wound healing, multiple sclerosis, disc degeneration, psoriasis, orthopedics, human longevity, and cancer. FibroBiologics represents the next generation of medical advancement in cell therapy and tissue regeneration.

Goal for Presentation: Build awareness

Additional Comments:

Who referred you to this application?:

What is your next catalyst (value inflection) update?

Endpoint data in 2026

Year Founded

2021

Lead Product in Development

Diabetic Foot Ulcer, Multiple Sclerosis, Psoriasis, Human Longevity

Development Phase of Lead Product

Phase II

Exchange

NASDAQ

Ticker

FBLG

CEO/Top Company Official

Pete OHeeron